Literature DB >> 17237185

My approach to intraductal lesions of the prostate gland.

M Pickup1, T H Van der Kwast.   

Abstract

The morphologically heterogeneous (intra)ductal lesions of the prostate frequently present a diagnostic challenge, particularly when found within prostate needle biopsies. By current convention, all high-grade intra-acinar and intraductal neoplastic lesions of prostatic origin fall under the diagnostic umbrella term: prostatic intraepithelial neoplasm (PIN). Although a long-standing contentious issue, some lesions currently adhering to the diagnostic criteria of PIN may actually represent the intraductal spread of (generally high grade) invasive cancer. Illustrating this fact, the well-described ductal subtype of prostatic adenocarcinoma is frequently associated with conventional-type acinar adenocarcinoma, and has a tendency to propagate within adjacent intact prostatic ducts. Clearly, the misdiagnosis of lesions representing invasive disease as preinvasive has the potential for unfavourable clinical sequelae. As yet, however, many of these lesions have escaped the establishment of reliable morphologic criteria or immunohistochemical differentiation for diagnosis. By defining stringent architectural and cytonuclear features specific for each of these lesions, it may be feasible to separate potentially sinister lesions from the subset of traditional (preinvasive) PIN lesions with limited clinical urgency. This review discusses the (intra)ductal lesions of the prostate, along with their differential diagnoses. Given the current state of knowledge, a pragmatic approach to their effective reporting is outlined, taking into consideration the clinical implications, as well as current guidelines for treatment and follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237185      PMCID: PMC1994484          DOI: 10.1136/jcp.2006.043224

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  67 in total

Review 1.  Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report.

Authors:  D G Bostwick; R Montironi; I A Sesterhenn
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

Review 2.  Prostatic intraepithelial neoplasia is a risk factor for cancer.

Authors:  D G Bostwick
Journal:  Semin Urol Oncol       Date:  1999-11

3.  Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study.

Authors:  J Y Ro; A G Ayala; K I Wishnow; N G Ordóñez
Journal:  Semin Diagn Pathol       Date:  1988-08       Impact factor: 3.464

4.  Normal histology of the prostate.

Authors:  J E McNeal
Journal:  Am J Surg Pathol       Date:  1988-08       Impact factor: 6.394

5.  Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression.

Authors:  D A Brinker; S R Potter; J I Epstein
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

6.  Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.

Authors:  H J Dawkins; L N Sellner; G R Turbett; C A Thompson; S L Redmond; J E McNeal; R J Cohen
Journal:  Prostate       Date:  2000-09-01       Impact factor: 4.104

Review 7.  Cellular and molecular pathology of prostate cancer precursors.

Authors:  C S Foster; D G Bostwick; H Bonkhoff; J E Damber; T van der Kwast; R Montironi; W A Sakr
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

Review 8.  Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.

Authors:  R Montironi; R Mazzucchelli; F Algaba; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

9.  Atypical basal cell hyperplasia of the prostate.

Authors:  J I Epstein; O A Armas
Journal:  Am J Surg Pathol       Date:  1992-12       Impact factor: 6.394

10.  Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.

Authors:  P A Abrahamsson; H Lilja; S Falkmer; L B Wadström
Journal:  Prostate       Date:  1988       Impact factor: 4.104

View more
  7 in total

Review 1.  The update of prostatic ductal adenocarcinoma.

Authors:  Tantan Liu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

2.  Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.

Authors:  Charlotte F Kweldam; Mark F Wildhagen; Ewout W Steyerberg; Chris H Bangma; Theodorus H van der Kwast; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

Review 3.  Intraductal carcinoma of prostate: a comprehensive and concise review.

Authors:  Jordan A Roberts; Ming Zhou; Yong Wook Park; Yong Wok Park; Jae Y Ro
Journal:  Korean J Pathol       Date:  2013-08-26

4.  Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.

Authors:  Amanda H Seipel; Fredrik Wiklund; N Peter Wiklund; Lars Egevad
Journal:  Virchows Arch       Date:  2013-02-27       Impact factor: 4.064

Review 5.  Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.

Authors:  A Marije Hoogland; Charlotte F Kweldam; Geert J L H van Leenders
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

6.  The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy.

Authors:  Jinge Zhao; Pengfei Shen; Guangxi Sun; Ni Chen; Jiandong Liu; Xin Tang; Rui Huang; Diming Cai; Jing Gong; Xingming Zhang; Zhibin Chen; Xiang Li; Qiang Wei; Peng Zhang; Zhenhua Liu; Jiyan Liu; Hao Zeng
Journal:  Oncotarget       Date:  2017-07-24

7.  HoxB13 expression in ductal type adenocarcinoma of prostate: clinicopathologic characteristics and its utility as potential diagnostic marker.

Authors:  Cheol Keun Park; Su-Jin Shin; Yoon Ah Cho; Jin Woo Joo; Nam Hoon Cho
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.